• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H1N1 暴露于 SARS-CoV-2 感染的恢复期可导致 hACE2 转基因小鼠肺部病理损伤加重。

H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice.

机构信息

Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People's Republic of China.

出版信息

Emerg Microbes Infect. 2021 Dec;10(1):1156-1168. doi: 10.1080/22221751.2021.1938241.

DOI:10.1080/22221751.2021.1938241
PMID:34060982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8205102/
Abstract

The risk of secondary infection with SARS-CoV-2 and influenza A virus is becoming a practical problem that must be addressed as the flu season merges with the COVID-19 pandemic. As SARS-CoV-2 and influenza A virus have been found in patients, understanding the in vivo characteristics of the secondary infection between these two viruses is a high priority. Here, hACE2 transgenic mice were challenged with the H1N1 virus at a nonlethal dose during the convalescent stage on 7 and 14 days post SARS-CoV-2 infection, and importantly, subsequent H1N1 infection showed enhanced viral shedding and virus tissue distribution. Histopathological observation revealed an extensive pathological change in the lungs related to H1N1 infection in mice recovered from SARS-CoV-2 infection, with severe inflammation infiltration and bronchiole disruption. Moreover, upon H1N1 exposure on 7 and 14 dpi of SARS-CoV-2 infection, the lymphocyte population activated at a lower level with T cell suppressed in both PBMC and lung. These findings will be valuable for evaluating antiviral therapeutics and vaccines as well as guiding public health work.

摘要

SARS-CoV-2 和甲型流感病毒(influenza A virus)二次感染的风险正在成为一个现实问题,因为流感季节与 COVID-19 大流行同时出现。由于已经在患者体内发现了 SARS-CoV-2 和甲型流感病毒,因此了解这两种病毒之间二次感染的体内特征是当务之急。在这里,在感染 SARS-CoV-2 后第 7 天和第 14 天的恢复期,用非致死剂量的 H1N1 病毒对 hACE2 转基因小鼠进行了挑战,重要的是,随后的 H1N1 感染显示出病毒脱落和病毒组织分布增加。组织病理学观察显示,从 SARS-CoV-2 感染中恢复的小鼠肺部与 H1N1 感染相关的广泛病理变化,严重的炎症浸润和细支气管破坏。此外,在 SARS-CoV-2 感染后第 7 天和第 14 天接触 H1N1 时,在 PBMC 和肺部中 T 细胞受到抑制的情况下,淋巴细胞群体的激活水平较低。这些发现对于评估抗病毒治疗药物和疫苗以及指导公共卫生工作将是有价值的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/80c9a3df6c6f/TEMI_A_1938241_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/3e1514dd4e02/TEMI_A_1938241_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/410de4c20b1a/TEMI_A_1938241_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/fd6966819f1b/TEMI_A_1938241_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/58c367d39358/TEMI_A_1938241_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/b2faf80c6bce/TEMI_A_1938241_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/80c9a3df6c6f/TEMI_A_1938241_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/3e1514dd4e02/TEMI_A_1938241_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/410de4c20b1a/TEMI_A_1938241_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/fd6966819f1b/TEMI_A_1938241_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/58c367d39358/TEMI_A_1938241_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/b2faf80c6bce/TEMI_A_1938241_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cec/8205102/80c9a3df6c6f/TEMI_A_1938241_F0006_OC.jpg

相似文献

1
H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice.H1N1 暴露于 SARS-CoV-2 感染的恢复期可导致 hACE2 转基因小鼠肺部病理损伤加重。
Emerg Microbes Infect. 2021 Dec;10(1):1156-1168. doi: 10.1080/22221751.2021.1938241.
2
Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.在哺乳动物模型中,H1N1和SARS-CoV-2的序贯感染加重了COVID-19的发病机制,联合疫苗接种是预防COVID-19和流感的有效方法。
Signal Transduct Target Ther. 2021 May 20;6(1):200. doi: 10.1038/s41392-021-00618-z.
3
Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.人恢复期血浆可保护K18-hACE2小鼠免受严重呼吸道疾病的侵害。
J Gen Virol. 2021 May;102(5). doi: 10.1099/jgv.0.001599.
4
Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.传染性克隆产生的 SARS-CoV-2 可导致感染 K18-Human ACE2 小鼠发生严重肺部疾病。
mBio. 2021 Apr 20;12(2):e00819-21. doi: 10.1128/mBio.00819-21.
5
Coinfection with influenza A virus enhances SARS-CoV-2 infectivity.甲型流感病毒的合并感染会增强 SARS-CoV-2 的感染性。
Cell Res. 2021 Apr;31(4):395-403. doi: 10.1038/s41422-021-00473-1. Epub 2021 Feb 18.
6
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.SARS-CoV-2 引起人类 ACE2 基因敲入小鼠肺部感染但不引起严重疾病。
J Virol. 2022 Jan 12;96(1):e0151121. doi: 10.1128/JVI.01511-21. Epub 2021 Oct 20.
7
Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.严重急性呼吸综合征冠状病毒 2 与甲型 H1N1pdm09 流感病毒共感染增强金黄地鼠肺炎的严重程度。
Clin Infect Dis. 2021 Jun 15;72(12):e978-e992. doi: 10.1093/cid/ciaa1747.
8
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.经鼻腔接种 SARS-CoV-2 后 K18-hACE2 小鼠的神经侵袭和脑炎。
Viruses. 2021 Jan 19;13(1):132. doi: 10.3390/v13010132.
9
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.K18-Human ACE2 转基因小鼠模型对 SARS-CoV-2 病毒感染剂量的反应可重现非重症和重症 COVID-19。
J Virol. 2022 Jan 12;96(1):e0096421. doi: 10.1128/JVI.00964-21. Epub 2021 Oct 20.
10
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在人血管紧张素转换酶2(hACE2)转基因小鼠中的致病性。
Nature. 2020 Jul;583(7818):830-833. doi: 10.1038/s41586-020-2312-y. Epub 2020 May 7.

引用本文的文献

1
The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps.SARS-CoV-2 与同时流行的病原体的相互作用:流行病学意义和当前的知识空白。
PLoS Pathog. 2023 Mar 8;19(3):e1011167. doi: 10.1371/journal.ppat.1011167. eCollection 2023 Mar.
2
Influenza Infection in Ferrets with SARS-CoV-2 Infection History.感染过 SARS-CoV-2 的雪貂中的流感感染。
Microbiol Spectr. 2022 Dec 21;10(6):e0138622. doi: 10.1128/spectrum.01386-22. Epub 2022 Oct 27.
3
Quo Vadis Influenza?流感将何去何从?

本文引用的文献

1
Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.严重急性呼吸综合征冠状病毒 2 与甲型 H1N1pdm09 流感病毒共感染增强金黄地鼠肺炎的严重程度。
Clin Infect Dis. 2021 Jun 15;72(12):e978-e992. doi: 10.1093/cid/ciaa1747.
2
A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana.路易斯安那州新型冠状病毒与流感病毒合并感染的病例系列
Respir Med Case Rep. 2020;31:101214. doi: 10.1016/j.rmcr.2020.101214. Epub 2020 Sep 9.
3
Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Mini-review of the literature.
China CDC Wkly. 2021 Dec 3;3(49):1046-1048. doi: 10.46234/ccdcw2021.254.
意大利患者 SARS-CoV-2 和甲型流感 A 合并感染致急性呼吸窘迫综合征:文献复习。
Int J Infect Dis. 2020 Aug;97:236-239. doi: 10.1016/j.ijid.2020.06.056. Epub 2020 Jun 18.
4
Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.纵向 COVID-19 分析表明,IL-1RA 和 IL-10 与疾病严重程度相关,而 RANTES 与轻症疾病相关。
JCI Insight. 2020 Jul 9;5(13):139834. doi: 10.1172/jci.insight.139834.
5
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.分析 COVID-19 患者的血清细胞因子表明,IL-6 和 IL-10 是疾病严重程度的预测因子。
Emerg Microbes Infect. 2020 Dec;9(1):1123-1130. doi: 10.1080/22221751.2020.1770129.
6
Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran.伊朗博季努尔德两例急性呼吸综合征死亡患者中新冠病毒与甲型流感病毒合并感染情况
J Med Virol. 2020 Nov;92(11):2319-2321. doi: 10.1002/jmv.26014. Epub 2020 May 25.
7
Co-infection with respiratory pathogens among COVID-2019 cases.COVID-19 病例中呼吸道病原体的合并感染。
Virus Res. 2020 Aug;285:198005. doi: 10.1016/j.virusres.2020.198005. Epub 2020 May 11.
8
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在人血管紧张素转换酶2(hACE2)转基因小鼠中的致病性。
Nature. 2020 Jul;583(7818):830-833. doi: 10.1038/s41586-020-2312-y. Epub 2020 May 7.
9
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.新型冠状病毒肺炎感染:人类冠状病毒的起源、传播及特征
J Adv Res. 2020 Mar 16;24:91-98. doi: 10.1016/j.jare.2020.03.005. eCollection 2020 Jul.
10
Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China.中国肺炎患者同时感染 SARS-CoV-2 和甲型流感病毒。
Emerg Infect Dis. 2020 Jun;26(6):1324-1326. doi: 10.3201/eid2606.200299. Epub 2020 Jun 17.